Skip to content
healthcare.dev

Atovaquone

NDC 31722-629, Atovaquone, suspension, from Camber Pharmaceuticals, Inc..

Product NDC
31722-629
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-629 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
31722-629-21317220629211 BOTTLE in 1 CARTON (31722-629-21) / 210 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2445304e-4b4e-4358-b098-31f3c49c52ef
  • NADAC price for package 31722062921

    GET /v1/drugs/nadac/31722062921

Use it

Look up 31722-629 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-629 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-629. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.